VON ESCHENBACH ANDREW C. — SEC Form 4 filings
SEC reporting owner CIK 1536529. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-05 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 6,059 shares, $99,808 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 18,559 shares, $306,708 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 12,500 shares @ $16.50 ($206,250) in Bausch & Lomb Corp, filed 2026-08-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bausch & Lomb Corp (BLCO) | Director | 6 | 2 legs · 6,059 sh · $99,808 | 2 legs · 18,559 sh · $306,708 | 4 |
| TriSalus Life Sciences, Inc. (TLSI) | Director | 2 | — | — | 3 |
Form 4 filings — VON ESCHENBACH ANDREW C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Bausch & Lomb Corp (BLCO) | Sale (S): 12,500 @ $16.50 · Sale (S): 6,059 @ $16.58 | EDGAR |
| 2026-05-28 | 4 | Bausch & Lomb Corp (BLCO) | Grant/award (A): 15,842 @ $15.78 | EDGAR |
| 2026-03-03 | 4 | Bausch & Lomb Corp (BLCO) | Purchase (P): 4,364 @ $18.30 · Grant/award (A): 4,364 @ $0 | EDGAR |
| 2025-05-28 | 4 | Bausch & Lomb Corp (BLCO) | Grant/award (A): 20,338 @ $0 | EDGAR |
| 2025-05-06 | 4 | Bausch & Lomb Corp (BLCO) | Purchase (P): 1,695 @ $11.76 | EDGAR |
| 2024-08-21 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-06 | 4 | Bausch & Lomb Corp (BLCO) | Grant/award (A): 14,696 @ $0 | EDGAR |
| 2024-06-05 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Gift (G): 35,000 (derivative) @ $0 · Gift (G): 35,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1536529 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →